GENB Generate Biomedicines, Inc.
$16.39
Generate Biomedicines, Inc. (GENB) is expected to report earnings on November 5, 2026, before the market open. The consensus earnings estimate is a loss of $0.50 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of +16.2% since its last earnings release on August 6, 2026.
Generate Biomedicines Missed Consensus Estimates
Thursday, August 6, 2026 · 7:00 AM ET
Earnings Date
3rd Quarter, Sep 2026
Nov 5
Thursday · 7:00 AM ET
Earnings Whisper
-
vs ($0.50)
Rev est $6.67M
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP
$16.62
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
Sector
Healthcare
Industry
Biotechnology